Artificial intelligence can predict which people who attend memory clinics will develop dementia within two years with 92 […]
Category: Uncategorized
Being precautionaryDiscussing therapeutic interventions a couple of weeks ago,1 I invoked the benefit:harm balance, and suggested three different […]
Back in February 2021, the UK government announced that £18.5m is being invested into clinical research into long […]
Over the past few decades the argument for the need for diversification within the surgical field has been […]
The government has committed “in principle” to creating a public repository of consultants’ practice details that sets out […]
Inozyme rebrand shows the biopharma in a fresher, purple light sharon.coey Fri, 12/17/2021 – 06:26
Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T data; AstraZeneca-Samsung COVID pact aliu Fri, 12/17/2021 – […]
The European Medicines Agency has recommended approval for use of Kineret in COVID-19 to the European Commission, which […]
The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.